top of page

No COVID, No Vaccine, a Fourth Shot & More

From eNewsletter 4/13/2022

DID YOU KNOW that data from BMC Endocrine Disorders using US population samples over a nine year span showed each 1-unit increase in serum levels of vitamin D3 (25-hydroxyvitamin D3 as nmol/L) was associated with an 11% lower risk of developing insulin resistance (associated with blood sugar disorders)? While the association was strongest in overweight individuals, even more vitamin D3 was necessary to raise the levels in obese persons, which we have alluded to on myriad occasions. Are you listening public health decision makers?!


Text Us We accept text messages. Type (847) 498-3422 and text away!

COVID-19 Vaccine Information View this document here.

Virus Prevention And Treatment Vaccines minimize COVID-19 related mortality and hospitalizations, but SARS-CoV-2 is here to stay. Moreover, it is not the only virus we fight. There are influenza (flu), norovirus (stomach flu), adenovirus (common cold), and four other coronaviruses (common cold), among others. Continue your immune support year-round. For more information, refer to our Prevent and Fight Viruses 2.0 Protocol.

COVID-19 Condition Monograph For those interested in conventional and integrative treatments for COVID-19 with over 250 references, this is our COVID-19 Condition Monograph.

Post-COVID Syndrome 2.0 The official diagnosis for post-COVID syndrome (PCS) are symptoms that last for 12 weeks or more. If you, a family member, friend, coworker, or neighbor is suffering from PCS, diligently following our Post-COVID Syndrome 2.0 Action Plan for purchase, or free to paid members here (must use the password), can bring measurable improvement.

Have a happy, healthy day! Steve and Bonnie Minsky

In Today's Issue...

  • Well Connect Feature: What Is Insulin?*

  • COVID-19 Update

  • April 20% OFF Sale Items

  • Chiro Corner NEW!

  • Pure Genomics

  • Blog Briefs

  • Well Connect Member Benefits *Paid Member Access Only

COVID-19 Update

Steve: What if you never had a COVID-19 infection or a vaccine? It is suggested that 60% of Americans have never gotten a COVID-19 infection and about 40% have not been vaccinated. That's a lot of people. It's still possible you may have been exposed to COVID-19 without knowing it, which may offer partial immunity, but you cannot rely on this for protection. If you are 60 and older, and/or you have comorbidities, such as obesity or blood sugar disorders, you are vulnerable to serious illness unless you take preventive steps. Moreover, the prevailing data suggest the combination of a previous SARS-CoV-2 infection and a respective vaccination, called hybrid immunity, seems to confer the greatest protection against SARS-CoV-2 infections. Second Booster or Fourth Shot? As we explained in detail two weeks ago in our newsletter, we do not agree with the FDA's suggestion to offer a fourth shot for those 50 and over unless one is severely immunocompromised. Brain Health New research from Brain, Behavior, and Immunity indicates that even for those who have steered clear of becoming infected with SARS-CoV-2, societal and lifestyle disruptions during the COVID-19 pandemic may have triggered inflammation in the brain that can affect mental health. In the first study to use magnetic resonance brain imaging (MRI) before and after COVID-19, researchers in Nature saw decreased gray matter, an overall reduction in brain volume, and cognitive decline. Not surprisingly, the drop in brain volume was near the olfactory (smell) part of the brain. Neurocognitive and psychiatric symptoms of mental illness, including posttraumatic stress disorder (PTSD), are alarmingly high among patients who have previously had COVID-19, even among those who were not hospitalized with the virus, according to new research presented at the Anxiety and Depression Association of America (ADAA) Conference 2022. Autoimmune Disease Throughout the pandemic, we've noticed that those with severe COVID-19 infections have symptoms that are similar to autoimmune disorder symptoms, such as blood vessel inflammation, rashes/skin conditions, and organ damage. Some have even developed full-blown autoimmune disorders, such as Type 1 diabetes, lupus and psoriatic arthritis. We suspect that the SARS-CoV-2 virus may be triggering the body to attack itself with autoantibodies, or antibodies that target the body’s own tissues. Even people who recover from a mild case of COVID-19 appear to have an 40% elevated risk for new-onset type 2 diabetes, according to new study in Diabetologia. mRNA Vaccine Side Effect A study from Annals of Medicine and Surgery tried to explain why one of the most common side effects from mRNA vaccines, tinnitus, occurs. The authors suggest anti-spike antibodies may react with antigens along the auditory (hearing) pathway and fuel an inflammatory reaction, but implore that more research be done. This is one of the most common side effects clients complain of. Blood Type O Those with blood type O had a four-fold risk of post-COVID syndrome after getting COVID-19 infection than other blood types, according to a study from Medrxiv. CDC Revises COVID Data The CDC reported 966,575 deaths from COVID-19 on March 18 after it corrected the data earlier that week, which reduced the death tallies in all age-groups, including children. It made adjustments to its COVID Data Tracker's mortality data on March 14 because its algorithm was accidentally counting deaths that were not COVID-19-related. The adjustment resulted in removal of 72,277 deaths previously reported across 26 states, including 416 pediatric deaths. The reduction cut the CDC's estimate of deaths in children by 24% to 1,341. Children accounted for about 19% of all COVID-19 cases, but less than 0.26% of cases resulted in death. Ivermectin One of the larger studies performed on those taking Ivermectin, the antiparastic drug used by many as a preventive and/or treatment for COVID-19, has published in JAMA Internal Medicine. I purposely have not reported Ivermectin studies performed in the United States because many do not trust the data. In this Malaysian study, high-risk patients with mild to moderate COVID-19 taking ivermectin treatment during early illness did not prevent progression to severe disease.


bottom of page